多omics综合分析确定KIF22和KRAS是三阴性乳腺癌的高度合成致命对
Shichen Miao1,2, Xiao Wang3,4, Qiming Gu2
1Department of Breast Surgery, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
研究人员在三阴性乳腺癌 (TNBC) 中发现了一种新的合成致命 (SL) 基因对,即KIF22和KRAS. 这一发现为TNBC提供了一个有前途的治疗标,有可能改善这种侵袭性癌症患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 生物信息学是一种生物信息学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性亚型.
- 合成致死性 (SL) 通过利用协同基因相互作用提供了向治疗方法.
- 了解TNBC异质性对于开发基于SL的有效治疗非常重要.
研究的目的:
- 描述TNBC异质性,并确定与高合成致死性 (HSL) 活动相关的基因.
- 探索SL对与恶性TNBC细胞之间的相互作用.
- 为了验证潜在的SL基因对用于向TNBC治疗.
主要方法:
- 使用多omics数据 (scRNA-seq,ST,bulkRNA-seq) 来进行TNBC的表征.
- 应用计算分析包括CytoTRACE,Slingshot,CellChat,hdWGCNA和机器学习.
- 通过体外和体内分子生物学和动物实验验验证的结果.
主要成果:
- 鉴定出一种新型的TNBC细胞HSL亚型,具有增强的干状性质和细胞间通信.
- 十个特征基因,包括KIF22,在TNBC中显著上调,与预后不佳相关.
- 在TNBC中实验验证KIF22和KRAS作为合成致命基因对.
结论:
- KIF22和KRAS形成TNBC特有的合成致命对,提供了一个有前途的治疗目标.
- 向KIF22在KRAS突变的TNBC细胞或KRAS在低KIF22表达细胞中的向抑制了增殖.
- 这项研究为TNBC未来基于SL的药物发现工作提供了基础.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
